Cargando…
High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis
Rheumatoid arthritis (RA) remains a prevalent disease worldwide that causes significant morbidity and mortality despite recent therapeutics. High mobility group box-1 (HMGB1) protein, originally appreciated as an intranuclear DNA binding protein, has been implicated as an integral mediator in the pa...
Autor principal: | Goldstein, Richard S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483447/ https://www.ncbi.nlm.nih.gov/pubmed/18557992 http://dx.doi.org/10.1186/ar2427 |
Ejemplares similares
-
Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumour necrosis factor signalling
por: Pullerits, Rille, et al.
Publicado: (2008) -
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis
por: Biscetti, Federico, et al.
Publicado: (2017) -
Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome
por: Wang, Li-Hong, et al.
Publicado: (2017) -
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009) -
Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis
por: Chapoval, Svetlana P.
Publicado: (2015)